ConductScience.org, home

Paper7654476

Aminoglycosides--50 years on.

Begg EJ and 1 other. Br J Clin Pharmacol, 1995. Cited by 224 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Aminoglycosides--50 years on. Papers, record 7654476. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7654476

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Aminoglycosides--50 years on.
PubMed
Journal
Br J Clin Pharmacol
PubMed
Year
1995
PubMed
Publication types
Historical Article, Journal Article, Review
PubMed
Citations, by iCite
224
iCite
Relative citation ratio, by iCite
7.49
iCite
Revised in PubMed
2018-11-13
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Begg EJE J
2Barclay MLM L

Source PubMed

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AminoglycosidesMajor topic
Animals
Eye Diseases
History, 20th Century
Humans
Kidney Diseases

Source PubMed

References88

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
13,349,791Variability in aminoglycoside pharmacokinetics in critically ill surgical patients.Crit Care Med1988https://conductscience.org/library/papers/3349791PubMed
23,288,112Comparison of two methods for determining in vitro postantibiotic effects of three antibiotics on Escherichia coli.Antimicrob Agents Chemother1988https://conductscience.org/library/papers/3288112PubMed
33,392,422Single, large, daily dosing versus intermittent dosing of tobramycin for treating experimental pseudomonas pneumonia.J Infect Dis1988https://conductscience.org/library/papers/3392422PubMed
43,293,977Cefotaxime optimal dosage in adult patients. A reappraisal.Drugs1988https://conductscience.org/library/papers/3293977PubMed
53,062,000General mechanisms of resistance to antibiotics.J Antimicrob Chemother1988https://conductscience.org/library/papers/3062000PubMed
62,914,447Aminoglycoside pharmacokinetics: dosage requirements and nephrotoxicity in trauma patients.Crit Care Med1989https://conductscience.org/library/papers/2914447PubMed
73,232,800Altered aminoglycoside pharmacokinetics in the critically ill.Anaesth Intensive Care1988https://conductscience.org/library/papers/3232800PubMed
82,498,520Adaptive resistance to aminoglycoside antibiotics in Pseudomonas aeruginosa.J Med Microbiol1989https://conductscience.org/library/papers/2498520PubMed
92,745,867A prospective randomised trial comparing individualised pharmacokinetic dosage prediction for aminoglycosides with prediction based on estimated creatinine clearance in critically ill patients.Intensive Care Med1989https://conductscience.org/library/papers/2745867PubMed
102,764,235Incidence of amikacin ototoxicity: a sigmoid function of total drug exposure independent of plasma levels.Am J Otolaryngol1989https://conductscience.org/library/papers/2764235PubMed
112,669,624Aminoglycoside-induced hearing loss in humans.Antimicrob Agents Chemother1989https://conductscience.org/library/papers/2669624PubMed
122,775,614Comparison of Sawchuk-Zaske and Bayesian forecasting for aminoglycosides in seriously ill patients.Br J Clin Pharmacol1989https://conductscience.org/library/papers/2775614PubMed
132,775,618Individualised aminoglycoside dosage based on pharmacokinetic analysis is superior to dosage based on physician intuition at achieving target plasma drug concentrations.Br J Clin Pharmacol1989https://conductscience.org/library/papers/2775618PubMed
142,681,115Determinants of efficacy and toxicity of aminoglycosides.J Antimicrob Chemother1989https://conductscience.org/library/papers/2681115PubMed
152,815,234Serial pharmacokinetic dosing of aminoglycosides: a community hospital experience.Ther Drug Monit1989https://conductscience.org/library/papers/2815234PubMed
162,328,198Failure of a nomogram to achieve target aminoglycoside concentrations.Br J Clin Pharmacol1990https://conductscience.org/library/papers/2328198PubMed
172,335,046Bayesian forecasting of serum gentamicin concentrations in intensive care patients.Clin Pharmacokinet1990https://conductscience.org/library/papers/2335046PubMed
182,195,890Once-daily dosing regimen for aminoglycoside plus beta-lactam combination therapy of serious bacterial infections: comparative trial with netilmicin plus ceftriaxone.Am J Med1990https://conductscience.org/library/papers/2195890PubMed
192,115,555Adaptive resistance to aminoglycoside antibiotics from first-exposure down-regulation.J Infect Dis1990https://conductscience.org/library/papers/2115555PubMed
202,202,080Aminoglycoside-induced ototoxicity.Toxicol Lett1990https://conductscience.org/library/papers/2202080PubMed

See all 88 references

Cited by87

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 224 citations.

PMIDTitleJournalYearIn PapersSource
42,473,667A rapid point-of-care test for vancomycin monitoring at the clinical bedside.iScience2026https://conductscience.org/library/papers/42473667PubMed
42,187,863Protecting Kidney Health in the First 1000 Days: The Pediatrician's Role in Safeguarding the Weakest.Diseases2026https://conductscience.org/library/papers/42187863PubMed
41,939,791Identification of small molecules that enhance aminoglycoside-mediated suppression of CFTR and NF1 nonsense mutations.Mol Ther Oncol2026https://conductscience.org/library/papers/41939791PubMed
41,462,666Experimental and Clinical Approaches to Preventing Aminoglycoside-Induced Ototoxicity: A Scoping Review.Antioxidants (Basel)2025https://conductscience.org/library/papers/41462666PubMed
39,180,707A universal optical aptasensor for antibiotics determination based on a new high-efficiency Förster resonance energy transfer pair.Mikrochim Acta2024https://conductscience.org/library/papers/39180707PubMed
38,648,490Intranasal neomycin evokes broad-spectrum antiviral immunity in the upper respiratory tract.Proc Natl Acad Sci U S A2024https://conductscience.org/library/papers/38648490PubMed
38,465,318Comparison of the effects of selected aminoglycoside antibiotics on motor behaviors in mice.Vet Res Forum2024https://conductscience.org/library/papers/38465318PubMed
38,460,106Spider's Silk as a Potential Source of Antibiotics: An Integrative Review.Probiotics Antimicrob Proteins2024https://conductscience.org/library/papers/38460106PubMed
38,389,933The phenomenon of phototoxicity and long-term risks of commonly prescribed and structurally diverse drugs.J Photochem Photobiol2024https://conductscience.org/library/papers/38389933PubMed
36,777,986Targeting Lower Serum Trough Concentrations: A New Gentamicin Dosing Strategy for Suspected Neonatal Early-Onset Sepsis.J Pediatr Pharmacol Ther2023https://conductscience.org/library/papers/36777986PubMed
36,015,365Degradable and Non-Degradable Chondroitin Sulfate Particles with the Controlled Antibiotic Release for Bacterial Infections.Pharmaceutics2022https://conductscience.org/library/papers/36015365PubMed
35,961,964Can intracellular Staphylococcus aureus in osteomyelitis be treated using current antibiotics? A systematic review and narrative synthesis.Bone Res2022https://conductscience.org/library/papers/35961964PubMed
35,664,584Nephroprotective Potential of a Standardized Extract of Bambusa arundinacea: In Vitro and In Vivo Studies.ACS Omega2022https://conductscience.org/library/papers/35664584PubMed
34,188,500Resistance Patterns from Urine Cultures in Children Aged 0 to 6 Years: Implications for Empirical Antibiotic Choice.Infect Drug Resist2021https://conductscience.org/library/papers/34188500PubMed
33,751,142Nonsense suppression therapies in human genetic diseases.Cell Mol Life Sci2021https://conductscience.org/library/papers/33751142PubMed
33,401,760Nanotheranostics: A Possible Solution for Drug-Resistant Staphylococcus aureus and their Biofilms?Nanomaterials (Basel)2021https://conductscience.org/library/papers/33401760PubMed
32,212,706How We Think about Targeting RNA with Small Molecules.J Med Chem2020https://conductscience.org/library/papers/32212706PubMed
32,002,369Evaluation of Amikacin Pharmacokinetics in Critically Ill Patients with Intra-abdominal Sepsis.Adv Pharm Bull2020https://conductscience.org/library/papers/32002369PubMed
31,775,233
Development of a Novel Pharmaceutical Formula of Nanoparticle Lipid Carriers of Gentamicin/α-Tocopherol and In Vivo Assessment of the Antioxidant Protective Effect of α-Tocopherol in Gentamicin-Induced Nephrotoxicity.
Antibiotics (Basel)2019https://conductscience.org/library/papers/31775233PubMed
31,739,573Antimicrobial Peptides as Anti-Infective Agents in Pre-Post-Antibiotic Era?Int J Mol Sci2019https://conductscience.org/library/papers/31739573PubMed

See all 87 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7654476

GET https://conductscience.org/api/papers/v1/7654476/references?page=2